The Heart Outcomes Prevention Evaluation (HOPE) Study
HOPE is considered a landmark study by doctors. It was an international study of more than 9,000 patients aged 55 or older who were at high risk for having cardiovascular events.29 HOPE studied the effect of ALTACE® on outcomes such as heart attack, stroke, and death from cardiovascular causes. Learn about the HOPE study.
The Clinical ALTACE® Real-World Efficacy (CARE) Study
CARE was an 8-week study that followed up with 11,100 patients who had mild-to-moderate hypertension to see how ALTACE® changed their blood pressure.32 Learn about the CARE study.
More
- View the HOPE study
- View the CARE study















